FDA Okays New Drug Keytruda to Treat Patients With Advanced Melanoma

September 6, 2014 10:40 AM

16 0

The FDA panel has given a green signal to a new drug Keytruda to treat patients with advanced melanoma.

In a latest announcement, the U.S. Food and Drug Administration revealed that Keytruda (pembrolizumab) received an approval for treatment of patients with advanced or unresectable melanoma who fail to respond to other drugs.

Read more

To category page